Sign In
Get Clay Free →

Suggestions

    Jeffrey Kadanoff P.Eng., MBA

    Senior finance and corporate development leader

    Jeffrey Kadanoff, P.Eng., MBA, currently serves as the Chief Financial Officer (CFO) at GHGSAT, a company specializing in satellite-based greenhouse gas monitoring. He has a robust background in finance and corporate development, with extensive public company CFO experience in both Canada and the United States.

    Professional Background::

    • GHGSAT: As CFO, Kadanoff plays a crucial role in overseeing the financial operations and strategic planning of the company.
    • Esplanade Ventures: Before his current role, he was the Managing Director at Esplanade Ventures, where he contributed to various investment initiatives.
    • Knight Therapeutics Inc.: Kadanoff was the CFO from its inception as a public company in 2014 until 2017. This role involved significant responsibilities in financial management within the pharmaceutical sector.
    • Bain & Company: He spent 14 years as a Principal at this top-tier management consulting firm, providing strategic consulting services.

    Education::

    • Kadanoff holds a Bachelor of Engineering with Distinction in Chemical Engineering and a Minor in Management from McGill University.
    • He also earned an MBA with Distinction from INSEAD, further enhancing his expertise in business management and finance.

    Kadanoff's experience combines technical engineering knowledge with extensive finance and strategic planning skills, making him a valuable asset in his current position at GHGSAT.12

    Related Questions

    What is GHGSAT's primary focus and mission?
    How did Jeffrey Kadanoff transition from Knight Therapeutics to GHGSAT?
    What are some notable projects Jeffrey Kadanoff has worked on at Esplanade Ventures?
    How has Jeffrey Kadanoff's experience at Bain & Company influenced his career?
    What are the key achievements of Jeffrey Kadanoff in the pharmaceutical industry?